Navegar

Colección

Datos Estadísticas

Lista de

Neovascularization, Pathologic
38
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys" (2018) Abiuso, A.M.B.;Varela, M.L.;Haro Durand, L. (...)Mondillo, C. European Journal of Cancer. 91:125-135
"Programmed cell senescence: Role of IL-6 in the pituitary" (2017) Sapochnik, M.; Fuertes, M.; Arzt, E. Journal of Molecular Endocrinology. 58(4):R241-R253
"Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis" (2017) Méndez-Huergo, S.P.; Blidner, A.G.; Rabinovich, G.A. Current Opinion in Immunology. 45:8-15
"In vivo hemin conditioning targets the vascular and immunologic compartments and restrains prostate tumor development" (2017) Jaworski, F.M.;Gentilini, L.D.;Gueron, G. (...)Vazquez, E.S. Clinical Cancer Research. 23(17):5135-5148
"RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors" (2016) Wu, Y.;Tedesco, L.;Lucia, K. (...)Stalla, G.K. Oncotarget. 7(36):57878-57893
"Inhibition of angiopoietin-1 (ANGPT1) affects vascular integrity in ovarian hyperstimulation syndrome (OHSS)" (2016) Scotti, L.;Abramovich, D.;Pascuali, N. (...)Parborell, F. Reproduction, Fertility and Development. 28(6):690-699
"Inhibition of angiopoietin-1 (ANGPT1) affects vascular integrity in ovarian hyperstimulation syndrome (OHSS)" (2016) Scotti, L.;Abramovich, D.;Pascuali, N. (...)Parborell, F. Reproduction, Fertility and Development. 28(6):690-699
"Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation" (2015) Ahmad, S.;Hewett, P.W.;Fujisawa, T. (...)Ahmed, A. Thrombosis and Haemostasis. 113(2):329-337
"Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model" (2015) Di Pietro, M.;Parborell, F.;Irusta, G. (...)Abramovich, D. Endocrinology. 156(4):1453-1463
"Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model" (2015) Di Pietro, M.;Parborell, F.;Irusta, G. (...)Abramovich, D. Endocrinology. 156(4):1453-1463
"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255
"OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis" (2014) Astorgues-Xerri, L. European journal of cancer (Oxford, England : 1990). 50(14):2463-2477
"OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis" (2014) Astorgues-Xerri, L. European journal of cancer (Oxford, England : 1990). 50(14):2463-2477
"Glycans and galectins in prostate cancer biology, angiogenesis and metastasis" (2014) Compagno, D.;Gentilini, L.D.;Jaworski, F.M. (...)Laderach, D.J. Glycobiology. 24(10):899-906
"Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases" (2014) Wan, X.;Corn, P.G.;Yang, J. (...)Navone, N.M. Science Translational Medicine. 6(252)
"Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases" (2014) Wan, X.;Corn, P.G.;Yang, J. (...)Navone, N.M. Science Translational Medicine. 6(252)
"Galectin-8: A matricellular lectin with key roles in angiogenesis" (2014) Troncoso, M.F.;Ferragut, F.;Bacigalupo, M.L. (...)Elola, M.T. Glycobiology. 24(10):907-914
"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors" (2014) Croci, D.O.;Cerliani, J.P.;Dalotto-Moreno, T. (...)Rabinovich, G.A. Cell. 156(4):744-758
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma" (2013) Massari, N.A.;Medina, V.A.;Cricco, G.P. (...)Rivera, E.S. Journal of Dermatological Science. 72(3):252-262
"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96
"Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas" (2012) Shan, B.;Schaaf, C.;Schmidt, A. (...)Renner, U. Journal of Endocrinology. 214(3):389-398
"Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma" (2012) Croci, D.O.;Salatino, M.;Rubinstein, N. (...)Rabinovich, G.A. Journal of Experimental Medicine. 209(11):1985-2000
"Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome" (2012) Abramovich, D.;Irusta, G.;Bas, D. (...)Tesone, M. Endocrinology. 153(7):3446-3456
"RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells" (2012) Shan, B.;Gerez, J.;Haedo, M. (...)Renner, U. Endocrine-Related Cancer. 19(1):13-27
"A natural antiviral and immunomodulatory compound with antiangiogenic properties" (2012) Bueno, C.A.; Lombardi, M.G.; Sales, M.E.; Alché, L.E. Microvascular Research. 84(3):235-241
"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer" (2011) Ferrando, M.;Gueron, G.;Elguero, B. (...)Vazquez, E. Angiogenesis. 14(4):467-479
"Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas" (2011) Luque, G.M.;Perez-Millán, M.I.;Ornstein, A.M. (...)Becu-Villalobos, D. Journal of Pharmacology and Experimental Therapeutics. 337(3):766-774
"Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance" (2010) Carlini, M.J.;Dalurzo, M.C.L.;Lastiri, J.M. (...)Lauría de Cidre, L.S. Human Pathology. 41(5):697-705
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis" (2008) Tesone, M.; Bilotas, M.; Barañao, R.I.; Meresman, G. Gynecologic and Obstetric Investigation. 66(SUPPL 1):10-18
"Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment" (2008) Villeneuve, J.;Galarneau, H.;Beaudet, M.-J. (...)Vallières, L. Brain Pathology. 18(3):401-414
"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft" (2007) Gazzaniga, S.;Bravo, A.I.;Guglielmotti, A. (...)Wainstok, R. Journal of Investigative Dermatology. 127(8):2031-2041
"Dopaminergic D2 receptor knockout mouse: An animal model of prolactinoma" (2006) Cristina, C.;García-Tornadú, I.;Díaz-Torga, G. (...)Bronstein M. Frontiers of Hormone Research. 35:50-63